Cris Loiren Rodriguez

Array ( [id] => 4513352 [patent_doc_number] => 07910331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Nucleic acids encoding murine IL-174' [patent_app_type] => utility [patent_app_number] => 12/616476 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26453 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910331.pdf [firstpage_image] =>[orig_patent_app_number] => 12616476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245699 [patent_doc_number] => 20100136020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'USES OF IL-174 ANTAGONISTS FOR INHIBITING A TH2 IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/614003 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8455 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136020.pdf [firstpage_image] =>[orig_patent_app_number] => 12614003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935987 [patent_doc_number] => 20110212104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'INFLAMMATORY BOWEL DISEASE BIOMARKERS AND RELATED METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/127212 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31402 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212104.pdf [firstpage_image] =>[orig_patent_app_number] => 13127212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502250 [patent_doc_number] => 08034343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Methods of treating inflammatory disorders of the lungs' [patent_app_type] => utility [patent_app_number] => 12/604289 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13348 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034343.pdf [firstpage_image] =>[orig_patent_app_number] => 12604289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501455 [patent_doc_number] => 20110263484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'SINGLE CHAIN FC TYPE III INTERFERONS AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 13/123144 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25275 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263484.pdf [firstpage_image] =>[orig_patent_app_number] => 13123144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487480 [patent_doc_number] => 20110251140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'PEPTIDE ANTAGONIST OF INTERLEUKIN-15 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/120855 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3934 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251140.pdf [firstpage_image] =>[orig_patent_app_number] => 13120855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4623804 [patent_doc_number] => 08003099 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Antibodies against human IL17 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/586893 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10804 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003099.pdf [firstpage_image] =>[orig_patent_app_number] => 12586893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987730 [patent_doc_number] => 20110098450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Antibody Molecules' [patent_app_type] => utility [patent_app_number] => 12/680087 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22205 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098450.pdf [firstpage_image] =>[orig_patent_app_number] => 12680087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515793 [patent_doc_number] => 07910701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Interleukin-17 receptor homologue' [patent_app_type] => utility [patent_app_number] => 12/565554 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34272 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910701.pdf [firstpage_image] =>[orig_patent_app_number] => 12565554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159642 [patent_doc_number] => 20110159011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'USES OF IL-22, IL-17, AND IL-1 FAMILY CYTOKINES IN AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/060695 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 28227 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159011.pdf [firstpage_image] =>[orig_patent_app_number] => 13060695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17164158 [patent_doc_number] => 11150250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-19 [patent_title] => Methods for diagnosing acute kidney injury or renal failure [patent_app_type] => utility [patent_app_number] => 13/061413 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51703 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251942 [patent_doc_number] => 20100028343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Il-17 homologous polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/549497 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 79738 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028343.pdf [firstpage_image] =>[orig_patent_app_number] => 12549497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220008 [patent_doc_number] => 20100055103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'CROSS-REACTIVE AND BISPECIFIC ANTI-IL-17A/F ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/547728 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25192 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055103.pdf [firstpage_image] =>[orig_patent_app_number] => 12547728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616573 [patent_doc_number] => 20100003251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Uses of IL-23 Agonists and Antagonists; Related Reagents' [patent_app_type] => utility [patent_app_number] => 12/546230 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11437 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003251.pdf [firstpage_image] =>[orig_patent_app_number] => 12546230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6482938 [patent_doc_number] => 20100008915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHODS FOR TREATING DISEASE USING AN ANTI-IL-21 RECEPTOR ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/541544 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20899 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008915.pdf [firstpage_image] =>[orig_patent_app_number] => 12541544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969034 [patent_doc_number] => 20110150871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'TREATMENT OF AN AUTOIMMUNE DISEASE USING IL-18 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/059435 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12167 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150871.pdf [firstpage_image] =>[orig_patent_app_number] => 13059435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499456 [patent_doc_number] => 20110262445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'ANTI-IL-12/IL-23 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/058914 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 58898 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262445.pdf [firstpage_image] =>[orig_patent_app_number] => 13058914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6511634 [patent_doc_number] => 20100210825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/540084 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82971 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210825.pdf [firstpage_image] =>[orig_patent_app_number] => 12540084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302865 [patent_doc_number] => 20090297517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'METHODS FOR TREATING IL-18 MEDIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/534755 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13815 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297517.pdf [firstpage_image] =>[orig_patent_app_number] => 12534755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374241 [patent_doc_number] => 20090311802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Isolated Soluble IL-TIF/IL-22 Receptor or Binding Protein Which Binds to IL-TIF/IL-22 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/512909 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10746 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311802.pdf [firstpage_image] =>[orig_patent_app_number] => 12512909 [rel_patent_id] =>[rel_patent_doc_number] =>)